Quick Answer
Cabaletta Bio, Inc. reported Net Income of -$167.86 million for fiscal year 2025.
Cabaletta Bio, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$167.86M | -44.9% |
| 2024 | -$115.86M | -71.2% |
| 2023 | -$67.67M | -27.7% |
| 2022 | -$52.98M | -14.4% |
| 2021 | -$46.29M | -38.8% |
| 2020 | -$33.34M | -96.8% |
| 2019 | -$16.94M | -38.9% |
| 2018 | -$12.20M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$44.87M | -46.5% | +0.6% |
| June 30, 2025 | -$45.13M | -63.5% | -25.6% |
| March 31, 2025 | -$35.94M | -43.5% | -17.3% |
| September 30, 2024 | -$30.63M | -86.2% | -11.0% |
| June 30, 2024 | -$27.60M | -90.5% | -10.2% |
| March 31, 2024 | -$25.05M | -58.0% | -52.3% |
| September 30, 2023 | -$16.45M | -43.9% | -13.5% |
| June 30, 2023 | -$14.49M | -12.2% | +8.6% |
- Cabaletta Bio, Inc. showed a decrease of -44.9% in Net Income compared to the prior fiscal year.
- Over the 2018–2025 period, Cabaletta Bio, Inc.’s net income has declined by 1275.6% (from -$12.20 million to -$167.86 million).
- The most recent figure is from Cabaletta Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: